Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026)
Quanterix (QTRX) posted Total Non-Current Liabilities of $81.0 million for Q1 2026, down 29.54% on a QoQ basis from $114.9 million in Q4 2025, and up 5.98% year-over-year from $76.4 million in Q1 2025.
Quanterix (QTRX) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
Quanterix's Total Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $81.0 million for Q1 2026.
- Quarterly Total Non-Current Liabilities rose 5.98% year-over-year to $81.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $81.0 million (up 5.98% YoY) and the FY2025 annual result came in at $114.9 million, up 50.26% from the prior year.
- Total Non-Current Liabilities was $81.0 million for Q1 2026 at Quanterix, down from $114.9 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $122.3 million in Q3 2025 and bottomed at $69.3 million in Q1 2023.
- A 5-year average of $80.5 million and a median of $76.4 million in 2025 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities dropped 9.96% — and 2025, when it jumped 71.81%.
- Quanterix's Total Non-Current Liabilities stood at $74.2 million in 2022, then increased by 4.38% to $77.4 million in 2023, then slipped by 1.21% to $76.5 million in 2024, then jumped by 50.26% to $114.9 million in 2025, then retreated by 29.54% to $81.0 million in 2026.
- Business Quant data shows QTRX's Total Non-Current Liabilities at $81.0 million in Q1 2026, $114.9 million in Q4 2025, and $122.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | 80.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 80.99 Mn |
| Dec 31, 2025 | 114.94 Mn |
| Sep 30, 2025 | 122.31 Mn |
| Jun 30, 2025 | 82.36 Mn |
| Mar 31, 2025 | 76.42 Mn |
| Dec 31, 2024 | 76.50 Mn |
| Sep 30, 2024 | 71.19 Mn |
| Jun 30, 2024 | 74.12 Mn |
| Mar 31, 2024 | 69.77 Mn |
| Dec 31, 2023 | 77.43 Mn |
| Sep 30, 2023 | 75.33 Mn |
| Jun 30, 2023 | 73.29 Mn |
| Mar 31, 2023 | 69.31 Mn |
| Dec 31, 2022 | 74.18 Mn |
| Sep 30, 2022 | 72.71 Mn |
| Jun 30, 2022 | 81.40 Mn |
| Mar 31, 2022 | 76.54 Mn |
| Dec 31, 2021 | 58.54 Mn |
| Mar 31, 2021 | 58.82 Mn |
| Dec 31, 2020 | 62.27 Mn |